Skip to main content
Equibles

ETRA · Electra Therapeutics, Inc.

Track ETRA — free

Use ETRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ETRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.25 At close · Sep 18
Rebalance outlook locked
Market Cap
$809.58M
Shares
61.10M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.25 Open$15.00 Day$13.25–15.50 Available close range$13.25–13.25 Avg vol available · 1d5.1M Short vol34% DataSep 2026–Sep 2026

The closing range uses available history since Sep 18, 2026; less than a full year is stored.

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Limited Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Limited
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Limited
Not enough data for a confident read.
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Limited
Not enough data for a confident read.

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
0 · 1 · 0
50 / 200-day cross
No cross Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Price range unavailable — no recent comparable closes.

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ETRA
Electra Therapeutics, Inc.
this stock
$809.58M — — — —
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.06B +12.1% +46.2% 29.9 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.80B +1.7% +20.8% 19.4 2.5%
MRNA
Moderna, Inc.
 $61.50B +422.3% +4.3% — 9.8%
ARGX
Argenx SE
 $60.93B +17.8% — — 2.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Volume
Short vol %
34%
As of
Sep 18, 2026
Short Total
View
Filings
Exempt Offerings
Offering
$184.1M
Filed
Oct 30, 2025
View

Performance

5D 20D 120D MTD YTD
ETRA — — — — —
SPY -0.3% -0.1% +20.1% -0.7% +11.7%
vs SPY — — — — —
Key facts CIK 2088082